CL2009000065A1 - Proteina aislada que comprende una pluralidad de dominios rrl para utilizarse como agente anti-microbiano; composicion farmaceutica que comprende dicha proteina aislada; metodo para tratar infeccion microbiana. - Google Patents

Proteina aislada que comprende una pluralidad de dominios rrl para utilizarse como agente anti-microbiano; composicion farmaceutica que comprende dicha proteina aislada; metodo para tratar infeccion microbiana.

Info

Publication number
CL2009000065A1
CL2009000065A1 CL2009000065A CL2009000065A CL2009000065A1 CL 2009000065 A1 CL2009000065 A1 CL 2009000065A1 CL 2009000065 A CL2009000065 A CL 2009000065A CL 2009000065 A CL2009000065 A CL 2009000065A CL 2009000065 A1 CL2009000065 A1 CL 2009000065A1
Authority
CL
Chile
Prior art keywords
isolated protein
rrl
domains
pharmaceutical composition
microbial infection
Prior art date
Application number
CL2009000065A
Other languages
English (en)
Inventor
Scott Parkinson
Laurent-Herve Perez
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CL2009000065A1 publication Critical patent/CL2009000065A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Proteína aislada que comprende una pluralidad de dominios RRL para utilizarse como agente anti-microbiano; composición farmacéutica que comprende dicha proteína aislada; método para tratar infección microbiana.
CL2009000065A 2008-01-15 2009-01-14 Proteina aislada que comprende una pluralidad de dominios rrl para utilizarse como agente anti-microbiano; composicion farmaceutica que comprende dicha proteina aislada; metodo para tratar infeccion microbiana. CL2009000065A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08150290 2008-01-15

Publications (1)

Publication Number Publication Date
CL2009000065A1 true CL2009000065A1 (es) 2009-11-06

Family

ID=39495862

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2009000065A CL2009000065A1 (es) 2008-01-15 2009-01-14 Proteina aislada que comprende una pluralidad de dominios rrl para utilizarse como agente anti-microbiano; composicion farmaceutica que comprende dicha proteina aislada; metodo para tratar infeccion microbiana.

Country Status (15)

Country Link
US (1) US20100286027A1 (es)
EP (1) EP2242763A1 (es)
JP (1) JP2011509966A (es)
KR (1) KR20100116612A (es)
CN (1) CN102037006A (es)
AR (1) AR070177A1 (es)
AU (1) AU2009204842A1 (es)
BR (1) BRPI0906517A2 (es)
CA (1) CA2711972A1 (es)
CL (1) CL2009000065A1 (es)
EA (1) EA201001138A1 (es)
MX (1) MX2010007727A (es)
PE (1) PE20091334A1 (es)
TW (1) TW200936155A (es)
WO (1) WO2009090168A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2570486A4 (en) * 2010-03-10 2013-08-14 Nat Univ Corp Hamamatsu MANUFACTURE OF AN ENTERITIS-CREATING FACTOR THROUGH HIGH-LIMIT ILLNESS ORAL BACTERIA AND HIGHLY SENSITIVE DETECTION METHOD THEREFOR
US9688726B2 (en) 2011-12-19 2017-06-27 Shanghai First People's Hospital Small molecule polypeptide for inhibiting inflammation
US11369657B2 (en) 2011-12-19 2022-06-28 Shanghai First People's Hospital Small molecule polypeptide for preventing and restraining inflammation and application of same
CN105176882B (zh) * 2015-10-17 2018-09-21 福清市默克兽医院 一种牛摩氏摩根菌性关节炎灭活疫苗及其制备方法
WO2019017940A1 (en) * 2017-07-19 2019-01-24 Rubius Therapeutics, Inc. COMPOSITIONS AND METHODS ASSOCIATED WITH MULTIMODAL THERAPEUTIC CELLULAR SYSTEMS FOR THE TREATMENT OF INFECTIOUS DISEASE
CN114671945A (zh) * 2022-01-14 2022-06-28 长沙学院 一种草鱼细菌小肽识别受体及制备方法与应用
CN120531854A (zh) * 2025-05-27 2025-08-26 复旦大学附属中山医院青浦分院(上海市青浦区中心医院) 多肽Nod-T3在制备治疗肺部疾病药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6040293A (en) * 1996-11-06 2000-03-21 The Regents Of The University Of California Clavanins

Also Published As

Publication number Publication date
MX2010007727A (es) 2010-10-26
CA2711972A1 (en) 2009-07-23
KR20100116612A (ko) 2010-11-01
US20100286027A1 (en) 2010-11-11
AU2009204842A1 (en) 2009-07-23
TW200936155A (en) 2009-09-01
AR070177A1 (es) 2010-03-17
EA201001138A1 (ru) 2011-02-28
WO2009090168A1 (en) 2009-07-23
BRPI0906517A2 (pt) 2019-09-24
EP2242763A1 (en) 2010-10-27
JP2011509966A (ja) 2011-03-31
CN102037006A (zh) 2011-04-27
PE20091334A1 (es) 2009-09-18

Similar Documents

Publication Publication Date Title
BR112014000665A2 (pt) composto, uso do mesmo, composição farmacêutica, agente antimicrobiano, e, método para previnir ou tratar uma infecção bacteriana
EA201270566A1 (ru) Противомикробные соединения и способы их получения и применения
CL2009000426A1 (es) Compuestos derivados de carbociclil/heterociclil-piridin-2-il-urea, inhibidores de topoisomerasa iv bacteriana; composicion farmaceutica; y su uso para el tratamiento de infecciones bacterianas
EA201270567A1 (ru) Противомикробные соединения и способы их получения и применения
SV2009003299A (es) Derivados de dihidropiridina de utilidad como inhibidores de la proteina quinasa
CL2008001367A1 (es) Compuestos derivados de heterociclos nitrogenados sustituidos; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una infeccion bacteriana.
BR112015027704A2 (pt) Composto, uso do mesmo e composição farmacêutica antibacteriana
CL2009001032A1 (es) Combinaciones de compuestos activos para controlar plagas animales; uso de las combinaciones; y procedimientos para controlar plagas animales.
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
ES2571041T3 (es) Composiciones antimicrobianas
CR11731A (es) Composiciones y procedimientos para su preparación y uso
EA201391536A1 (ru) Противомикробные соединения и способы их получения и применения
EP3117832C0 (en) Treatment of microbial infections
CL2008001462A1 (es) Composicion farmaceutica esteril que comprende un fosfolipido; metodo para preservar una composicion farmaceutica de la contaminacion microbiana; y solucion para tratar lentes de contacto
EA201190144A1 (ru) Изотиазолилоксифениламидины и их применение в качестве фунгицидов
CL2012003266A1 (es) Polisacarido de semillas de tamarindo para usarse en el tratamiento de infecciones microbianas; composicion farmacéutica y/o dermocosmética antimicrobiana que contiene dicho polisacárido; uso de un polisacárido de semilla de tamarindo ; metodo para tratar y/o prevenir a un paciente que tiene una infeccion microbiana.
BRPI0712607A8 (pt) métodos de tratamento de acidente vascular cerebral
BR112013014189A8 (pt) composição farmacêutica, uso de um agente de potencialização e uso de uma composição
BRPI0913300A2 (pt) composto, processo para o preparo e uso do mesmo, método de tratamento de infecção bacteriana em um animal, e, composição farmacêutica.
EA201270568A1 (ru) Антимикробные композиции и способы их получения и применения
AR077372A1 (es) Composiciones y metodos para tratar infecciones oftalmicas oticas o nasales
BRPI1006875A2 (pt) composição farmacêutica, bactérias, uso de bactérias vivas, e, métodos para tratar um animal.
HK1243951A1 (zh) 抗微生物组合和其在治疗微生物感染中的用途
UA107346C2 (en) Use of nifuratel to treat infections caused by atopobium species
BRPI0910884A2 (pt) composição imunogênica, método para tratar ou prevenir infecção ou doença estafilocócicas, e, uso de uma composição imunogênica.